… replacement because the efficacy of the novel agents has not been evaluated in this setting.
… -threatening bleeding in patients receiving a novel oral anticoagulant. While the rationale for …

… This study aims to review the published literature concerning the use of novel oral
anticoagulants (NOACs) in the treatment and prevention of venous thromboembolism (VTE) and to …

… and dose adjustments, and variations in anticoagulant activity that are affected by diet,
concomitant drugs and genetic variations. Novel oral anticoagulants (nOACs) have emerged as …

… Oral anticoagulation with warfarin is an effective treatment for prevention of ischemic stroke
… been modified with the introduction of the novel oral anticoagulants (NOACs) – dabigatran, a …

… , the efficacy and safety of the novel oral anticoagulants were … the value of novel oral
anticoagulants under other special … the value of novel oral anticoagulants by comparing them with …

… properties of the new anticoagulants, the most recent trials assessing their safety and efficacy
as well as potential advantages and disadvantages of using these novel drugs in real life. …

… ,” “warfarin,” “new oral anticoagulant,” “oral factor Xa inhibitor,” and “oral thrombin inhibitor.”
… the safety and efficacy of any new oral anticoagulant compared to oral anticoagulation with …

… Here, we compare the clinical efficacy and safety profiles of these new drugs. In addition,
we … This has led to the search for novel oral anticoagulants (NOACs) that offer equivalent or …

… Oral anticoagulation (OAC) has shown to be highly effective in preventing stroke and …
the development of novel oral anticoagulants (NOACs), which may offer efficacious and safer …

… We found that the novel oral anticoagulants significantly … The novel oral anticoagulants may
potentially address some … and a more predictable anticoagulant effect, thus allowing fixed-…